Global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs.
- Year invested 2015
- Investment Stage Public/PIPES
- Sectors
- Investment Status Historic
- Associated Team
- Website strongbridgebio.com/
- Company Status IPO/Acquired (by Xeris Pharmaceuticals Nasdaq: XERS)